In addition, Zang et al. found that miR-122-5p also plays a role in the development of DKD, miR-122-5p inhibited forkhead box protein P2 (FOXP2) transcription, resulting in decreased cell viability, and inhibit E-cadherin expression, increasing α-SMA expression. Here, FOXP2 is linked to diabetic kidney disease.